Association of neutralizing breadth against SARS-CoV-2 with inoculation orders of heterologous prime-boost vaccines

BACKGROUND: Emerging evidence suggests heterologous prime-boost COVID-19 vaccination as a superior strategy than homologous schedules. Animal experiments and clinical observations have shown enhanced antibody response against influenza variants after heterologous vaccination; however, whether the in...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yufang, Lu, Yingying, Zhou, Caili, Tong, Gangling, Gao, Manman, Zhan, Yan, Wang, Yan, Liang, Ran, Li, Yawei, Gao, Tianjiao, Wang, Li, Zhang, Muyun, Cheng, Jin, Gong, Jun, Wang, Jimin, Zhang, Wei, Qi, Junhua, Cui, Miao, Zhu, Longchao, Xiao, Fenglian, Zhu, Linyu, Xu, Yunsheng, Zheng, Zhihua, Zhou, Zhiyu, Cheng, Zhengjiang, Hong, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Clinical and Translational Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181311/
https://www.ncbi.nlm.nih.gov/pubmed/35679856
http://dx.doi.org/10.1016/j.medj.2022.05.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181311/
https://www.ncbi.nlm.nih.gov/pubmed/35679856
http://dx.doi.org/10.1016/j.medj.2022.05.003

Ejemplares similares